Condition
Type 1 Diabetes (T1D)
Overweight
Obesity
Healthy Volunteers
Locations
Germany
Start date
07/05/2026
Identifiers
Trial ID NN6497-8309,
NCT number NCT07578584,
Eudract number 2025-523978-16
NCT number NCT07578584,
Eudract number 2025-523978-16
Summary
The purpose of this clinical study is to find out if NNC0497-0040 is safe, tolerable and effective for healthy people living with normal weight or overweight, people living with overweight or obesity and people who have type 1 diabetes and are living with overweight or obesity. There are 2 study treatments in this study, where participants will get either NNC0497-0040, the new treatment being tested or placebo, a treatment that has no active medicine in it. Participants will be in this clinical study for up to 29 weeks.
Trial Overview:
Treatment
DRUG: NNC0497-0040
DRUG: Placebo
Study type
INTERVENTIONAL
Trial duration
May 07 2026 - Feb 18 2028
Participants
146
Phase
I
Are you eligible?
Gender
Male and female
Age
18 to 55 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.